ABRYSVO
Google image searchProduct monograph
Active ingredients
rsv subgroup a stabilized prefusion f protein, 60 MCG/0.5 ML
rsv subgroup b stabilized prefusion f protein, 60 MCG/0.5 ML
DIN: 02544040
Dosage form(s): KIT, POWDER FOR SOLUTION
Route(s) of administration: INTRAMUSCULAR
Schedule: Schedule D
Company: PFIZER CANADA ULC
Date: 22-MAY-2024
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07B — VIRAL VACCINES (ATC, ATC/DDD)
- J07BX — Other viral vaccines (ATC, ATC/DDD)
- J07BX05 — RESPIRATORY SYNCYTIAL VIRUS VACCINE (ATC/DDD)
Reference brand drug: Abrysvo, Arexvy